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few days. He had no goitre, thyroid, eye or skin disease. Thyroid microsomal antibodies were present in a titre of 1 in 25 600 (normal less than 1 in 400). His chest pain, tachycardia and sweating improved further and he went home after 10 days in hospital. Both the ECG (Figure 1b ) and thyroid function showed improvement (T4 247 nmol/L, FT4 45 pmol/L, T3 5.6 nmol/L, TSH50.1 mU/L). He became pain-free within two weeks of the start of treatment.
After four weeks of treatment he developed cutaneous hypersensitivity to carbimazole and was changed to propylthiouracil. He continued to improve clinically, biochemically (T4 160 nmol/L, T3 2.8 nmol/L, TSH50.1 mU/L) and electrocardiographically ( Figure  1c ). Propranolol was stopped and thyroxine was added when he opted for block and replacement treatment. Paired sera (admission and convalescence) were negative for viral studies. He was well, pain-free, and clinically and biochemically euthyroid with a completely normal ECG when last seen six months after presentation. His exercise ECG revealed normal exercise tolerance, an adequate blood pressure and heart rate response and no evidence of ischaemic heart disease or ST-T segment changes. Fasting lipids were normal (total cholesterol 3.9, triglycerides 1.4, high-density lipoprotein cholesterol 1.18 mmol/L).
COMMENT
In a patient with chest pain and ST-T segment changes on the ECG, myocardial ischaemia due to coronary atherosclerosis is the most likely diagnosis. We did not perform angiography, but we think that coronary atherosclerosis was not the diagnosis in this case for several reasons. He was young and had no risk factor other than smoking. The duration of his chest pain was longer then we would expect in angina and his sweating was more probably related to hyperthyroidism than to myocardial ischaemia. His cardiac enzymes and exercise ECG were normal. Furthermore, the temporal relationship of the ST-segment changes to the clinical and the biochemical improvement of his hyperthyroidism led us to believe that the ECG changes were secondary to untreated hyperthyroidism. The cause of the hypoxia remains unclear, but it was mild and of questionable signi®cance.
ST-T segment changes in the ECG are seen in many conditions other than coronary atherosclerosisÐe.g. pericardial disease, hypothyroidism, electrolyte abnormalities, digoxin therapy, cardiomyopathies. Some ST-T segment changes have been described in otherwise normal individuals,`normal variants'. ST segment changes may also occur in hyperthyroidism, as has been reported on at least three occasions 2±4 . Yokoyama reported a young Japanese man with thyrotoxic periodic paralysis who had ST segment depression during such an episode precipitated by hypokalaemia (serum potassium 2.7 mmol/L) 2 . Gorobets et al. reported a lowering of the ST segment with treatment in patients with Graves' disease and a direct correlation between serum T3 and the area under the ST segment in leads II, III, aVF and V 5 of the ECG. Pronounced ST-T segment changes were also reported in two young female patients with Graves' disease and systemic myopathy; they had no overt cardiac disease, and the changes disappeared with treatment 4 . The ®rst patient had ST segment depression in V 5±6 , the second had T wave inversion in the same leads. Our patient showed two striking differences from the reported cases with ST changes: ®rst, he had no evidence of peripheral myopathy; second, he had ST segment elevation rather than depression (hence the initial diagnosis of acute myocardial coronary syndrome). Changes suggestive of myo-pericardial involvement were reported in 22% of the 123 hyperthyroid patients studied by Hoffman and Lowrey but neither depression nor elevation of the ST segment was reported 5 .
We do not recommend thyroid function testing in all patients with ST segment changes, but clinicians should be aware that hyperthyroidism can present with atypical chest pain and ECG changes.
